Evidence map›Paper›PMID 32265319›Full record

ArticleJournal of lipid research2020

Skin barrier lipid enzyme activity in Netherton patients is associated with protease activity and ceramide abnormalities.

Jeroen van Smeden, Hanin Al-Khakany, Yichen Wang, Dani Visscher, Nicole Stephens, Samira Absalah, Herman S Overkleeft, Johannes M F G Aerts, Alain Hovnanian, Joke A Bouwstra

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Ceramides in Skin Health and Disease: An Update.American journal of clinical dermatology · 2021
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jeroen van SmedenLeiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Centre for Human Drug Research, Leiden, The Netherlands.
Hanin Al-KhakanyLeiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Yichen WangINSERM UMR1163, Imagine Institute, Paris Descartes University, Paris, France.
Dani VisscherLeiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Nicole StephensLeiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Samira AbsalahLeiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
Herman S OverkleeftDepartment of Bio-organic Synthesis, Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
Johannes M F G AertsMedical Biochemistry Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
Alain HovnanianINSERM UMR1163, Imagine Institute, Paris Descartes University, Paris, France; Department of Genetics Necker-Enfants Malades Hospital, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France.
Joke A BouwstraLeiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. Electronic address: mailto:bouwstra@lacdr.leidenuniv.nl.
Leiden University · NLDélégation Paris 5 · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals with Netherton syndrome (NTS) have increased serine protease activity, which strongly impacts the barrier function of the skin epidermis and leads to skin inflammation. Here, we investigated how serine protease activity in NTS correlates with changes in the stratum corneum (SC) ceramides, which are crucial components of the skin barrier. We examined two key enzymes involved in epidermal ceramide biosynthesis, β-glucocerebrosidase (GBA) and acid-sphingomyelinase (ASM). We compared in situ expression levels and activities of GBA and ASM between NTS patients and controls and correlated the expression and activities with

Indexed as

Lipid MetabolismCeramidesHumansNetherton SyndromePeptide HydrolasesSkinCeramidesPeptide Hydrolasesactivity-based probe labelingenzyme expressionichthyosis linearis circumflexa (Netherton syndrome)in situ zymographymass spectrometrystratum corneum

Identifiers

PMID32265319
PMCPMC7269766
OpenAlexW3014435360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.